• Title/Summary/Keyword: Dyspepsia

Search Result 412, Processing Time 0.027 seconds

Risk Factors for Recurrent Abdominal Pain in Children with Nonorganic Acute Abdominal Pain

  • Piriyakitphaiboon, Varisa;Sirinam, Salin;Noipayak, Pongsak;Sirivichayakul, Chukiat;Pornrattanarungsri, Suwanna;Limkittikul, Kriengsak
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • v.25 no.2
    • /
    • pp.129-137
    • /
    • 2022
  • Purpose: The purpose of this study was to identify the risk factors for recurrent abdominal pain (RAP) in children who presented with nonorganic acute abdominal pain. Methods: A retrospective, single study was conducted on 2-15-year-old children diagnosed with nonorganic acute abdominal pain at the pediatric outpatient department of Vajira Hospital, Nawamindradhiraj University, between January 2015 and December 2019. The potential risk factors were analyzed using univariate and multivariate analyses. Results: Of the 367 patients with nonorganic acute abdominal pain, 94 (25.6%) experienced RAP within three months. In this group with RAP, 76 patients (80.8%) were diagnosed with functional gastrointestinal disorders, including functional dyspepsia, irritable bowel syndrome, functional abdominal pain-not otherwise specified, and functional constipation. History of gastrointestinal infection (p=0.011), mental health problems (p=0.022), abdominal pain lasting ≥7 days (p<0.001), and change in stool frequency (p=0.001) were the independent risk factors associated with RAP in children with nonorganic acute abdominal pain; their odds ratios and 95% confidence intervals were 3.364 (1.314-8.162), 3.052 (1.172-7.949), 3.706 (1.847-7.435), and 2.649 (1.477-4.750), respectively. Conclusion: RAP is a common problem among children who first present with nonorganic acute abdominal pain. The identification of risk factors may provide proper management, especially follow-up plans for this group in the future.

A Case Report on the Use of Heart Rate Variability and the Treatment Effect of Bunshimgi-eum on Autonomic Dysfunction After Cerebral Infarction (뇌경색 후 발생한 자율신경 장애에 대해 심박변이도로 살펴본 분심기음의 효과 증례보고 1례)

  • Jun-seok Kim;Ji-hyeon Kang;Seo-hyun Kim;Chae-eun Kim;Na-yeon Kim;Woo-seok Jang
    • The Journal of Internal Korean Medicine
    • /
    • v.44 no.1
    • /
    • pp.66-76
    • /
    • 2023
  • Background: The aim of this study is to investigate the use of heart rate variability on a stroke patient with autonomic dysfunction and the effectiveness of Bunshimgi-eum. Case report: The patient showed autonomic dysfunction, including chest discomfort, 煩燥 (sweating, anxiety, insomnia, nausea, lightheadedness), and abdomen discomfort (dyspepsia, heartburn) after ischemic stroke. She was treated with a herbal medicine (Bunshimgi-eum) through complex Korean medicine treatment. The effect was evaluated using heart rate variability (HRV), Mini-Mental State Examination-DS (MMSE-DS), mean pulse rate, and subjective percentage of symptoms. After treatment, the HRV score, MMSE-DS score, and subjective percentage of symptoms improved, and the pulse rate decreased from the upper boundary value. Discussion: The results suggest that HRV may be useful in evaluating stroke patients with autonomic dysfunction and that Bunshimgi-eum is suitable for treatment.

Case Report of Metabolic Dysfunction-Associated Fatty Liver Disease Treated with Saenggangunbi-tang (대사이상 관련 지방간질환의 생간건비탕 치험 1례)

  • Cho Hyun Hwang;Juyoung Lee;Eunkyung Lee;Eungyeong Jang;Youngchul Kim;Jang-Hoon Lee
    • The Journal of Internal Korean Medicine
    • /
    • v.44 no.2
    • /
    • pp.138-145
    • /
    • 2023
  • Objective: This study identified the effects of Korean medicine treatment on a patient with metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A 43-year-old man with MAFLD was treated with Saenggangunbi-tang with regular exercise from August 13, 2022, to December 24, 2022, to reduce fatigue and dyspepsia and to improve laboratory findings, such as liver enzymes and lipid profiles. We observed changes in symptoms and laboratory findings during the approximately four-month treatment. Results: Treatment with Saenggangunbi-tang resulted in decreased serum levels of liver enzymes, triglycerides, hepatic steatosis index scores, and clinical symptoms. During the treatment, the patient performed regular exercise; however, there was no significant change in body weight until the end of the study. Conclusion: This study suggests the availability of Saenggangunbi-tang as a therapeutic option for managing MAFLD patients.

Korean Medicine Review and Treatment Suggestions for the Main Symptoms of Long COVID (Long COVID의 주요 증상에 대한 한의학적 고찰과 치료 제안)

  • Yosun, Hwang;Euna, Lee;Hyungwoo, Kim
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.36 no.5
    • /
    • pp.155-162
    • /
    • 2022
  • Even after testing negative for COVID-19, some patients continue to struggle with a variety of symptoms such as fatigue, shortness of breath, gastrointestinal problems and neurological problems. The World Health Organization (WHO) defined long COVID (Post COVID-19 conditions) as "A disease occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months, that cannot be explained by an alternative diagnosis." As a possible pathological mechanism of long COVID, three hypotheses are proposed: the persistence of the infectious state due to the residual virus, the persistent inflammatory response, and the autoimmune response. The main symptoms of long COVID are shortness of breath (dyspnea), abdominal pain and dyspepsia, fatigue, cognitive problems (brain fog), anosmia and dysgeusia, and chest pain, palpitations and tachycardia. In the Chinese guidelines, COVID-19 patients were divided into mild, moderate, severe, and recovery, and prescriptions with effective therapeutic effects were summarized to encourage combined treatment of chinese and western medicine. Globally, only symptomatic therapy is recommended for long COVID, but a specific treatment has not yet been proposed. Recently, morbidity code for post COVID-19 conditions was created, and it is planned to announce guidelines for long COVID treatment and management in the first half of 2023. In line with this trend, the Korean medical community needs to make efforts to prepare treatment guidelines for patients with long COVID.

Effects of Korean Medicine Treatment at Public Health Center for Post-acute COVID-19 Patients: A Retrospective Case-series of 11 patients (일개 보건지소에 내원한 급성기 후 코로나-19 환자들의 특성 및 한의 치료 효과 분석: 사례군 연구)

  • Chang-hwan Yu;Kwan-Il Kim;Hee-Jae Jung;Beom-joon Lee
    • The Journal of Korean Medicine
    • /
    • v.44 no.2
    • /
    • pp.132-148
    • /
    • 2023
  • Objectives: The purpose of this study is to determine the clinical features of post-acute COVID-19 syndrome and the effectiveness and safety of Korean medicine treatment at the Public health center. Methods: The study was conducted among 11 patients with post-acute COVID-19 syndrome who attended a single public health center from January to December 2022. We retrospectively analyzed the charts of 11 patients and collected clinical characteristics, previous treatments, Korean medicine treatments, outcome variables (Numeral Rating Scale (NRS), Leicester Cough Questionnaire (LCQ), Visual Analog Scale (VAS)), adverse events, etc. Results: Of the 11 patients, six were women, and the average age of all patients was 68.27±12.31 years. The most common symptom were cough(n=9, 81.82%) and sore throat(n=9, 81.82%), followed by sputum, fatigue, rhinorrhea, and loss of appetite, etc. All 11 patients were treated with herbal medicine, with Samso-eum(n=6, 54.55%), Yeonkyopaedok-san(n=5, 45.45%), and Haengso-tang(n=3, 27.27%) being the most commonly used. After herbal medicine treatment, the median cough NRS decreased from 5 to 1, and the median sore throat NRS decreased from 4 to 1, both of which were statistically significant. One patient reported adverse event of dyspepsia and heartburn, but it was mild. Conclusions: The study presented the clinical features of the post-acute COVID-19 syndrome and suggested that Korean medicine treatment at public health centers may be effective and safe in alleviating associated symptoms.

A Case of Long Term Survival of Gastric Cancer on Trastuzumab Based Treatment (Trastuzumab으로 장기 생존한 진행성 위암 증례 1예)

  • Jihye Park;Sang Kil Lee
    • Journal of Digestive Cancer Research
    • /
    • v.3 no.1
    • /
    • pp.39-41
    • /
    • 2015
  • We report a case of long term survival on trastuzumab based treatment. A 51-year-old man with dyspepsia received esophagogastroduodenoscopy on another hospital and was transferred for further evaluation under the impression of advanced gastric cancer, Borrmann type III, antrum, lesser curvature. After further studies in our hospital, the patient was diagnosed with advanced gastric cancer, adenocarcinoma, moderately differentiated with pancreas invasion and lymph node metastasis. Though he was recommended with chemotherapy, he refused and left for oriental herbal medicine. After 4 months, the patient was admitted through emergency room for hematemesis. Diagnosed with gastric outlet obstruction due to gastric cancer in the antrum, he underwent the placement of pyloric metal stent insertion. Immunohistochemical staining showed HER2-positive finding, and he was treated with palliative chemotherapy of trastuzumab, capecitabine, and cisplatin, 16 times during 11 months. The patient showed neutropenia after the therapy, so cisplatin was left out, and he received combination chemotherapy of trastuzumab and capecitabine, 34 times during 25 months. Response evaluation showed no remarkable change in extent of primary stomach cancer, lymph node metastasis, and regression of metastasis site, and the patient is continuing chemotherapy.

  • PDF

Response to Capecitabine Treatment Following Palliative Chemotherapy for Metastatic Colorectal Cancer: A Case Report (고식적 항암화학요법 후에 Capecitabine 단독치료에 반응을 보인 전이성 대장암 환자 1례)

  • Dae Hwa Park;Ju Seok Kim;Sun Hyung Kang;Hee Seok Moon;Jae Kyu Sung;Hyun Yong Jeong
    • Journal of Digestive Cancer Research
    • /
    • v.5 no.1
    • /
    • pp.66-69
    • /
    • 2017
  • Approximately 40% of patients with colorectal cancer have metastatic lesions at the time of diagnosis, and chemotherapy is generally prescribed for these patients. Though several drugs are used, 5-FU has long been the backbone of chemotherapy for colorectal cancer. Capecitabine is an oral 5-FU prodrug approved by the FDA in 2005 and is used alone or in combination for treatment of colorectal cancer. Recently, capecitabine has been used for a number of off-label indications, including the treatment of advanced or metastatic colorectal cancer. Here, we report a rare case of a 59-year-old woman, diagnosed with metastatic colorectal cancer who first presented with abdominal discomfort and dyspepsia. She showed a partial response to palliative first line FOLFOX chemotherapy, which had to be stopped due to peripheral neuropathy, as a side effect. She was next put on a second line chemotherapy regimen with capecitabine alone, since then she showed good treatment response without any disease progression.

  • PDF

The Effect of Abdominal Daoyin and Lymphatic Circulation Technique in combination with Whole-body Articulation Mechanics Technique Therapy on Indigestion after Constitutional Diet: A Case Report (체질 식이 이후에 발생한 소화불량에 대한 전신관절역학 치료 중 복부도인술과 림프순환기법의 효과: 증례보고)

  • Young-Sung Kang;Hye-Jin Park;Dong-Yun Baek;Sang-Hyun Lee;Eui-Hyoung Hwang
    • The Journal of Churna Manual Medicine for Spine and Nerves
    • /
    • v.18 no.2
    • /
    • pp.75-84
    • /
    • 2023
  • Objectives This study aimed to report the effectiveness of abdominal Daoyin and lymphatic circulation technique in conjunction with whole-body articulation mechanics technique therapy in treating indigestion. Methods Three patients who suffered from dyspepsia and abscess after consuming foods incompatible with their constitution, following a 10-year implementation of a constitutional diet at a local Korean Medicine clinic, visited a Korean Medicine Hospital. The patients underwent treatment with abdominal Daoyin and lymphatic circulation technique. The effects of these techniques were analyzed using a retrospective record analysis method. Results Following the implementation of abdominal Daoyin and lymphatic circulation technique for indigestion, the numeric rating scale scores improved significantly. Case 1 improved from 9 to 2, case 2 from 6 to 0, and case 3 from 5 to 1. Conclusions While acknowledging the limitations of being a case report involving only three patients and the absence of specialized outcomes for digestive issues, this report may provide a preliminary basis for considering the efficacy of Chuna manual therapy in indigestion treatment.

A Case Report of Dizziness Diagnosed Dam Hun Treated with Korean Medicine in a Patient Hospitalized at a Korean Medicine Hospital (한방병원에 입원한 담훈으로 변증한 어지럼 환자에 대한 한방 치료 1례)

  • Sang-yoon Kim;Yen-min Wang;Gil-geun Baek;Sang-hun Yun;Yu-jin Lee;Hyung-chul Lee;Man-ho Kang;Sung-hwan Park
    • The Journal of Internal Korean Medicine
    • /
    • v.44 no.5
    • /
    • pp.911-919
    • /
    • 2023
  • Objective: The purpose of this study is to report the efficacy of using Korean medicine treatment on dizziness diagnosed as Dam Hun. Methods: The patient received herbal medicine treatment of Banhabakchulchunma-tang and acupuncture from May 18, 2023 to June 3, 2023. To evaluate the treatment, we used the Korean Version of the Dizziness Handicap Inventory (K-DHI) to measure dizziness. The degree of dizziness, headache, and dyspepsia was also evaluated using the Visual Analogue Scale (VAS). Results: The patient's VAS scores improved after treatment. The change in the K-DHI scores showed that the patient's dizziness symptoms were relieved. Conclusions: The results of this study suggest that Korean medicine therapies may be effective for treating dizziness.

A Case Report of Korean Medicine Treatment Including Samchulgunbi-tang-gagambang in a Patient with Vestibular Neuritis (비위허약으로 변증된 전정신경염 환자의 삼출건비탕가감방을 포함한 한의 치료 치험 1례)

  • Ye-seul Park;Jeong-hui Kim;Ju-yeon Song;Ho-ryong Yoo;In-chan Seol;Yoon-sik Kim
    • The Journal of Internal Korean Medicine
    • /
    • v.44 no.4
    • /
    • pp.757-764
    • /
    • 2023
  • Background: Vestibular neuritis is a common cause of acute unilateral peripheral vestibulopathy. Vestibular neuritis is the second most common disease among patients with dizziness. Clinical symptoms of vestibular neuritis include the sudden onset of vertigo with spontaneous nystagmus, unsteady gait, nausea, and vomiting that last from days to weeks. However, even after the vertigo disappears, difficulty maintaining balance while walking may persist for weeks to months. Antihistamines, serotonin receptor blockers, and benzodiazepine vestibular suppressants are widely used as symptomatic treatments to reduce the severity of symptoms that occur in the acute phase. Case Summary: A patient diagnosed with acute vestibular neuritis was treated with acupuncture, moxibustion, and herbal medicine. We used the visual analog scale (VAS) to assess each symptom and the vertigo score to observe the effect of treatment. After treatment, the VAS scores for each symptom and the vertigo score decreased, and the severity of nystagmus was reduced. Conclusion: This study suggests that Korean medicine treatments, including Samchulgunbi-tang-gagam, could be effective in improving the clinical symptoms of vestibular neuritis.